Stay updated with breaking news from Hatim husain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers are conducting a phase 2 trial to determine if adding abemaciclib to osimertinib can overcome resistance to osimertinib in EGFR-mutant non-small cell lung cancer. ....
/PRNewswire/ BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to. ....